Pages that link to "Item:Q3506537"
From MaRDI portal
The following pages link to AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem (Q3506537):
Displaying 50 items.
- Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy (Q264091) (← links)
- Discretization of semilinear bang-singular-bang control problems (Q276875) (← links)
- Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity (Q326554) (← links)
- Local controllability and optimal control for a model of combined anticancer therapy with control delays (Q335260) (← links)
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach (Q335265) (← links)
- A numerical method for nonconvex multi-objective optimal control problems (Q404521) (← links)
- The nature of Hopf bifurcation for the Gompertz model with delays (Q409877) (← links)
- Structural stability investigation of bang-singular-bang optimal controls (Q415388) (← links)
- Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments (Q415424) (← links)
- On an extension of a mathematical model for tumor anti-angiogenesis (Q425828) (← links)
- Analysis of an optimal control problem connected to bioprocesses involving a saturated singular arc (Q480026) (← links)
- Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method (Q541886) (← links)
- Analysis of the Hopf bifurcation for the family of angiogenesis models (Q549750) (← links)
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics (Q662618) (← links)
- On probabilistic certification of combined cancer therapies using strongly uncertain models (Q739722) (← links)
- Dynamics and control of a mathematical model for metronomic chemotherapy (Q745131) (← links)
- Tangency property and prior-saturation points in minimal time problems in the plane (Q829581) (← links)
- Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays (Q902503) (← links)
- On optimal delivery of combination therapy for tumors (Q1042733) (← links)
- Effect of awareness programs and travel-blocking operations in the control of HIV/AIDS outbreaks: a multi-domains SIR model (Q1625717) (← links)
- Optimal control of vibration-based micro-energy harvesters (Q1626543) (← links)
- An optimal control approach for the treatment of solid tumors with angiogenesis inhibitors (Q1649031) (← links)
- Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth (Q1678296) (← links)
- Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia (Q1712819) (← links)
- Closed-loop control of tumor growth by means of anti-angiogenic administration (Q1714906) (← links)
- Ebola model and optimal control with vaccination constraints (Q1716956) (← links)
- Dynamical behaviour of a tumor-immune system with chemotherapy and optimal control (Q1728939) (← links)
- Optimal combined radio- and anti-angiogenic cancer therapy (Q1730431) (← links)
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors (Q1743540) (← links)
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers (Q1790751) (← links)
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis (Q1794472) (← links)
- A dynamic programming approach for approximate optimal control for cancer therapy (Q1949602) (← links)
- On the role of the objective in the optimization of compartmental models for biomedical therapies (Q2025280) (← links)
- On the role of pharmacometrics in mathematical models for cancer treatments (Q2026619) (← links)
- Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors (Q2033852) (← links)
- Transition therapy: tackling the ecology of tumor phenotypic plasticity (Q2070285) (← links)
- Pitfalls in applying optimal control to dynamical systems: an overview and editorial perspective (Q2081952) (← links)
- Stability analysis of the family of tumour angiogenesis models with distributed time delays (Q2199481) (← links)
- Global solvability and optimal control to a haptotaxis cancer invasion model with two cancer cell species (Q2234289) (← links)
- Optimal control and pattern formation for a haptotaxis model of solid tumor invasion (Q2334162) (← links)
- Numerical solution for a problem arising in angiogenic signalling (Q2335309) (← links)
- A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy (Q2390073) (← links)
- Optimal control of effector-tumor-normal cells dynamics in presence of adoptive immunotherapy (Q2671040) (← links)
- Dynamical modeling and optimal control of landfills (Q2799318) (← links)
- Tumor Development Under Combination Treatments with Anti-angiogenic Therapies (Q2820388) (← links)
- Qualitative analysis of tumor growth model under antiangiogenic therapy - choosing the effective operating point and design parameters for controller design (Q2830286) (← links)
- Bifurcations and Chaotic Dynamics in a Tumour-Immune-Virus System (Q4607525) (← links)
- Multiobjective approach in the treatment of cancer (Q5001039) (← links)
- Optimal control for a mathematical model for chemotherapy with pharmacometrics (Q5001339) (← links)
- Periodic solutions for a model of tumor volume with anti-angiogenic periodic treatment (Q5029392) (← links)
